537 related articles for article (PubMed ID: 31318794)
41. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
[TBL] [Abstract][Full Text] [Related]
42. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
[TBL] [Abstract][Full Text] [Related]
43. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?
Gollub MJ; Blazic I; Bates DDB; Campbell N; Knezevic A; Gonen M; Lynn P; Weiser MR; Garcia-Aguilar J; Hötker AM; Cercek A; Saltz L
Eur Radiol; 2019 Apr; 29(4):1733-1742. PubMed ID: 30280248
[TBL] [Abstract][Full Text] [Related]
44. Total Neoadjuvant Therapy Is a Predictor for Complete Pathological Response in Patients Undergoing Surgery for Rectal Cancer.
Horesh N; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Suarez E; Emile SH; Wexner SD
J Gastrointest Surg; 2022 Dec; 26(12):2579-2584. PubMed ID: 36224480
[TBL] [Abstract][Full Text] [Related]
45. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
[TBL] [Abstract][Full Text] [Related]
46. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
Fokas E; Allgäuer M; Polat B; Klautke G; Grabenbauer GG; Fietkau R; Kuhnt T; Staib L; Brunner T; Grosu AL; Schmiegel W; Jacobasch L; Weitz J; Folprecht G; Schlenska-Lange A; Flentje M; Germer CT; Grützmann R; Schwarzbach M; Paolucci V; Bechstein WO; Friede T; Ghadimi M; Hofheinz RD; Rödel C;
J Clin Oncol; 2019 Dec; 37(34):3212-3222. PubMed ID: 31150315
[TBL] [Abstract][Full Text] [Related]
47. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
[TBL] [Abstract][Full Text] [Related]
49. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
50. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
Petrelli F; Sgroi G; Sarti E; Barni S
Ann Surg; 2016 Mar; 263(3):458-64. PubMed ID: 24263329
[TBL] [Abstract][Full Text] [Related]
51. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
[TBL] [Abstract][Full Text] [Related]
52. Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview.
Guida AM; Sensi B; Formica V; D'Angelillo RM; Roselli M; Del Vecchio Blanco G; Rossi P; Capolupo GT; Caricato M; Sica GS
Biol Direct; 2022 Jun; 17(1):16. PubMed ID: 35698084
[TBL] [Abstract][Full Text] [Related]
53. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
54. Association between neoadjuvant chemoradiation and survival for patients with locally advanced rectal cancer.
Sun Z; Adam MA; Kim J; Turner MC; Fisher DA; Choudhury KR; Czito BG; Migaly J; Mantyh CR
Colorectal Dis; 2017 Dec; 19(12):1058-1066. PubMed ID: 28586509
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
[TBL] [Abstract][Full Text] [Related]
56. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
57. Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment: A Meta-Anaysis of Randomized Controlled Trials.
Gabbani M; Giorgi C; Napoli G; Tebano U; Perrone MS; Missiroli S; Berretta M; Mandarà M; Zaninelli M; Luca N; Grigolato D; Muraro M; Rinaldi G; Pinton P; Fiorica F
Clin Colorectal Cancer; 2022 Dec; 21(4):297-308. PubMed ID: 36210320
[TBL] [Abstract][Full Text] [Related]
58. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
59. The Effectiveness and Safety of Open Versus laparoscopic Surgery for Rectal Cancer after Preoperative Chemo-radiotherapy: A Meta-Analysis.
Zhang JJ; Guo BL; Zheng QX; Chen ZY
Comb Chem High Throughput Screen; 2019; 22(3):153-159. PubMed ID: 30987563
[TBL] [Abstract][Full Text] [Related]
60. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
Petrelli F; Coinu A; Lonati V; Barni S
Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
